StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Caplin Point Laboratories Limited
NSE:CAPLIPOINT.NS
Sector
Location
Market Cap
USD 1.82 B
Share Price
USD 23.55
Avg Daily Volume
135,219
Change (1 day)
-1.14%
Change (1 year)
29.72%
Change (YTD)
-19.40%
Caplin Point Laboratories Limited EBIT Margin for the year ending March 31, 2025: 29.99%
Caplin Point Laboratories Limited EBIT Margin is 29.99% for the year ending March 31, 2025, a -11.00% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Caplin Point Laboratories Limited EBIT Margin for the year ending March 31, 2024 was 33.69%, a 9.32% change year over year.
-
Caplin Point Laboratories Limited EBIT Margin for the year ending March 31, 2023 was 30.82%, a 0.71% change year over year.
-
Caplin Point Laboratories Limited EBIT Margin for the year ending March 31, 2022 was 30.60%, a 1.77% change year over year.
-
Caplin Point Laboratories Limited EBIT Margin for the year ending March 31, 2021 was 30.07%, a -4.10% change year over year.
Competitors
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
Divi's Laboratories Limited
USD 79.54
DIVISLAB.NS
-0.27
-0.34%
ALK-Abelló A/S
USD 30.42
ALK-B.CO
-0.16
-0.54%
Nahdi Medical Company
USD 34.29
4164.SR
-0.21
-0.61%
Rohto Pharmaceutical Co.,Ltd.
USD 13.97
4527.T
+0.05
0.35%
Hypera S.A.
USD 4.85
HYPE3.SA
-0.04
-0.79%
J. B. Chemicals & Pharmaceuticals Limited
USD 18.72
JBCHEPHARM.NS
-0.11
-0.56%
Almirall, S.A.
USD 12.79
ALM.MC
-0.08
-0.64%
Organon & Co.
USD 9.94
OGN
-0.08
-0.80%
Dermapharm Holding SE
USD 40.03
DMP.DE
-0.92
-2.24%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
Divi's Laboratories Limited
USD 79.54
DIVISLAB.NS
-0.27
-0.34%
ALK-Abelló A/S
USD 30.42
ALK-B.CO
-0.16
-0.54%
Nahdi Medical Company
USD 34.29
4164.SR
-0.21
-0.61%
Rohto Pharmaceutical Co.,Ltd.
USD 13.97
4527.T
+0.05
0.35%
Hypera S.A.
USD 4.85
HYPE3.SA
-0.04
-0.79%
J. B. Chemicals & Pharmaceuticals Limited
USD 18.72
JBCHEPHARM.NS
-0.11
-0.56%
Almirall, S.A.
USD 12.79
ALM.MC
-0.08
-0.64%
Organon & Co.
USD 9.94
OGN
-0.08
-0.80%
Dermapharm Holding SE
USD 40.03
DMP.DE
-0.92
-2.24%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%